niridazole has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nelson, DS; Nelson, M | 1 |
| Chiang, T; Deodhar, SD; Lee, VW; Mahmoud, AF; Watten, KS | 1 |
2 other study(ies) available for niridazole and EHS Tumor
| Article | Year |
|---|---|
Macrophages and resistance to tumours: influence of agents affecting macrophages and delayed-type hypersensitivity on resistance to tumours inducing concomitant immunity.
Topics: Animals; Carrageenan; Depression, Chemical; Fibrosarcoma; Hypersensitivity, Delayed; Immunity; Immunity, Innate; Macrophages; Mice; Niridazole; Reserpine; Sarcoma, Experimental; Silicon Dioxide | 1978 |
Effects of the immunosuppressive drug niridazole in isogeneic and allogeneic mouse tumor systems in vivo.
Topics: Animals; Immunosuppressive Agents; Lymphatic Metastasis; Male; Mice; Mice, Inbred A; Mice, Inbred C57BL; Neoplasm Transplantation; Niridazole; Sarcoma 180; Sarcoma, Experimental | 1976 |